NBI-74788, Crinecerfont placebo for oral capsules
NBI-74788-CAH3003
Phase 3 small_molecule active
Quick answer
NBI-74788, Crinecerfont placebo for oral capsules for Classic Congenital Adrenal Hyperplasia (CAH) is a Phase 3 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- Classic Congenital Adrenal Hyperplasia (CAH)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active